Wednesday, October 27, 2021

Baring Private Equity Asia Announces Agreement to Sell Lumenis Surgical Business to Boston Scientific for $ 1.07 Billion | News

Must Read

YOKNEAM, Israel and HONG KONG, March 3, 2021 / PRNewswire / – Baring Private Equity Asia (BPEA) and Lumenis today announced that they have entered into a definitive agreement to sell Lumenis Surgical Business to Boston Scientific (NYSE: BSX) in a transaction valued at $ 1.07 billion, subject to closing adjustments. The surgical sector includes laser and fiber solutions for minimally invasive surgical procedures in urology and ENT.

Lumenis’ high growth aesthetics and vision business will continue to operate under the ownership of BPEA. This strategic sale of the Surgery activity will allow Lumenis to accelerate its investments in both areas – in R&D, in…

Read more

News Highlights Business

  • Headline: Baring Private Equity Asia Announces Agreement to Sell Lumenis Surgical Business to Boston Scientific for $ 1.07 Billion | News
  • Check all news and articles from the Business news updates.
Disclaimer: If you need to update/edit this article then please visit our help center. For Latest Updates Follow us on Google News

More Articles Like This

Latest News